Chairman
Dr Graham E Kelly,
Dr Kelly was appointed Chairman of MEI in April 2002. Dr Kelly founded Novogen Limited and has spent nearly 30 years in medical research involving drug development, immunology, surgery and cancer. Dr Kelly was senior research fellow in experimental surgery in the Faculty of Medicine at the University of Sydney. He developed the beta 1, 3-glucan and isoflavone intellectual property now owned by the Novogen Group. Dr Kelly was Executive Chairman of Novogen between 1997 and 2000 and will continue to act as project leader for phenoxodiol.
President and CEO
Christopher Naughton,
Mr Naughton is the President and CEO of MEI. He is also the Managing Director of Novogen Limited. Mr Naughton has degrees in Economics from the Australian National University and in Law from the University of New South Wales. He has completed the Program for Management Development at the Harvard Business School and is admitted to practise as an attorney in New South Wales. After working in merchant banking he has spent the last 15 years in the pharmaceutical industry including appointments as Director of Wellcome Australia Limited and in world wide business development with the Wellcome Foundation Limited in the UK
Company Secretary
David Ross Seaton, aged 47, BBus, MCom, CPA
Mr Seaton is the Chief Financial Officer of Novogen Limited and the Company Secretary of MEI. He holds a degree in Business Studies as well as a Master of Commerce degree from the University of New South Wales. He has completed management development programs at Northwestern University in Chicago as well as Duke University and the London Business School. He has 16 years experience in the pharmaceutical industry and prior to joining Novogen in 1999 was the Finance Director of GlaxeWellcome Australia Limited. Mr Seaton was also Finance Director of Wellcome Australia Limited before its merger with Glaxo in 1995.
updated 28th June, 2002
| © Copyright 1996-2015 irasia.com Ltd. All rights reserved. |
|
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website. |